There are 339 resources available
Neuro toxicity
Presenter: Michel Obeid
Session: Management of toxicities from immunotherapy
Resources:
Slides
Webcast
Q&A
Presenter: All Speakers
Session: Management of toxicities from immunotherapy
Resources:
Webcast
New ESMO guidelines
Presenter: John Haanen
Session: Management of toxicities from immunotherapy
Resources:
Slides
Webcast
Q&A
Presenter: All Speakers
Session: Proffered Paper session 1
Resources:
Webcast
Invited Discussant abstract 4O
Presenter: Solange Peters
Session: Proffered Paper session 1
Resources:
Slides
Webcast
Q&A
Presenter: All Speakers
Session: Proffered Paper session 1
Resources:
Webcast
1O - Dynamic circulating tumour DNA (ctDNA) response to neoadjuvant (NA) atezolizumab (atezo) and surgery (surg) and association with outcomes in patients (pts) with NSCLC
Presenter: Mark Kris
Session: Proffered Paper session 1
Resources:
Abstract
Slides
Webcast
2O - IMpower010: biomarkers of disease-free survival (DFS) in a Phase 3 study of atezolizumab (atezo) vs best supportive care (BSC) after adjuvant chemotherapy in stage IB-IIIA NSCLC
Presenter: Caicun Zhou
Session: Proffered Paper session 1
Resources:
Abstract
Slides
Webcast
4O - Nivolumab (NIVO) + ipilimumab (IPI) versus chemotherapy (chemo) as first-line (1L) treatment for advanced NSCLC (aNSCLC) in CheckMate 227 Part 1: efficacy by KRAS, STK11, and KEAP1 mutation status
Presenter: Suresh Ramalingam
Session: Proffered Paper session 1
Resources:
Abstract
Slides
Webcast
Case presentation
Presenter: John Haanen
Session: Management of toxicities from immunotherapy
Resources:
Webcast